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ABSTRACT
RSV is the major cause of severe bronchiolitis in in-
fants, and severe bronchiolitis as a result of RSV is as-
sociated with subsequent asthma development. A bi-
ased Th2 immune response is thought to be responsi-
ble for neonatal RSV pathogenesis; however, molecular
mechanisms remain elusive. Our data demonstrate, for
the first time, that IL-4R is up-regulated in vitro on hu-
man CD4 T cells from cord blood following RSV stimu-
lation and in vivo on mouse pulmonary CD4 T cells
upon reinfection of mice, initially infected as neonates.
Th cell-specific deletion of Il4ra attenuated Th2 re-
sponses and abolished the immunopathophysiology
upon reinfection, including airway hyper-reactivity, eo-
sinophilia, and mucus hyperproduction in mice infected
initially as neonates. These findings support a patho-
genic role for IL-4R on Th cells following RSV reinfec-
tion of mice initially infected as neonates; more impor-
tantly, our data from human cells suggest that the
same mechanism occurs in humans. J. Leukoc. Biol.
93: 933–942; 2013.
Introduction
RSV is the leading cause of acute respiratory tract infections in
infants younger than 1 year of age [1, 2]. Typically children are
infected with RSV in their first RSV season, and 50% of them are
reinfected by 2 years of age [3, 4]. Long-term resistance to RSV
infection does not develop, and reinfection is common, particu-
larly in those with chronic lung or heart diseases, where severity
of the illness is much greater [5]. Although there is considerable
worldwide, clinical impact from RSV infection, we have neither
vaccines nor specific therapeutics against RSV infection. Develop-
ment of vaccines or therapeutics has been slow as a result of lim-
ited understanding of the virus, the host immune system at the
time of initial infection, and the interaction between the virus
and the host immune system.
Studies have demonstrated the importance of age at the time
of initial RSV infection in determining the pathophysiological
responses [6–11]. In humans, severe RSV infection in infants
leads to respiratory dysfunction that can persist into early adult-
hood [12–15]. In mice, we have demonstrated that age of initial
infection with RSV determines respiratory function in later life
[8, 9]. Mice infected with RSV as neonates (7 days of age) de-
velop long-term airway dysfunction [8], whereas mice infected
initially as weanlings fail to do so [9]. Studies from other labora-
tories have demonstrated further that mice infected as neonates
respond to RSV reinfection with a skewed Th2 immune response
[10, 11]. Increased susceptibility to RSV and disease severity in
infants are thought to be, in part, a result of the developmental
state of their immune system [16, 17], although other factors,
such as airway size and maturation status of the lung, may also
contribute to the pathology observed.
In humans, Th2 cytokines IL-4 and IL-13 and their receptors
have been associated with severe RSV disease [18–23]. In mouse
models, IL-4/13 and their receptors have been shown to play a
key role in the multiple pathophysiologies associated with infant
RSV infection, including airway hyper-reactivity, eosinophilic in-
flammation, and mucus hyperproduction [18–23]. Interestingly,
IL-4 and IL-13 share a common receptor, the type II IL-4R, which
is composed of IL-4R and IL-13R1 and is thought to be re-
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sponsible for the pathological changes observed in asthma and
RSV-associated disease [20, 24, 25]. IL-4 also binds to a second
receptor, the type I receptor, which is composed of IL-4R and a
 chain and is believed to initiate Th2 differentiation. All of these
data point to a potential role of IL-4R in RSV pathogenesis in
infants.
Here, we confirm that upon reinfection, mice infected initially
with RSV as neonates responded with a skewed Th2 immune re-
sponse associated with airway hyper-reactivity, eosinophilia, and
mucus hyperproduction. This is not the case when the initial in-
fection occurs in adults. The immunophysiological changes fol-
lowing reinfection of neonatally infected mice correlated with
increased expression of IL-4R on pulmonary CD4 Th cells and
elevated proliferation of these cells, especially the Th2 subset.
Specific deletion of Il4ra from Th cells attenuated pulmonary
Th2 responses and abolished the immunopathophysiology associ-
ated with RSV reinfection. Validating these data in the human
system, we observed elevated IL-4R expression on CD4 Th
cells from cord blood following stimulation with RSV in vitro.
Collectively, our data reveal a mechanism, whereby IL-4R signal-
ing on Th cells in neonates results in an exaggerated Th2 im-
mune response upon reinfection with RSV and adds significantly




BALB/c breeder pairs and female adult mice (6–8 weeks old) were purchased
from Harlan Laboratories (Indianapolis, IN, USA) and were maintained under
a specific, pathogen-free condition in the Division of Animal Care at LSUHSC
(New Orleans, LA, USA). Breeders were time-mated, and pups born on the
same date were used for experiments. The CD4 T cell-specific, IL-4R-defi-
cient mice (LckcreIL4R/Lox) were generated by crossing IL4RLox/Lox
BALB/c mice and LckcreIL4R/ BALB/c mice (gifts from Drs. Debroski
Herbert and Frank Brombacher, University of California, San Francisco, USA,
and University of Cape Town, South Africa). In these mice, Cre recombinase
is under the control of the T cell-specific promoter Lck; however,
LckcreIL4R/Lox mice showed effective deletion of Il4ra in CD4 T cells but
incomplete and variable deletion in other T cells, including CD8 T cells,
NKT cells, and T cells [26].
All animal protocols were prepared in accordance with the Guide for the
Care and Use of Laboratory Animals [27] and were approved by the Institu-
tional Animal Care and Use Committee at LSUHSC.
Human cord or peripheral blood samples
Cord and peripheral blood samples were obtained with informed, written con-
sent from term neonatal subjects (between 38 and 41 weeks of gestation), de-
livered at the Children’s & Women’s Health Centre of British Columbia (Van-
couver, BC, Canada), and from healthy adult volunteers at the Child & Family
Research Institute (Vancouver, BC, Canada), respectively. Consent was ob-
tained for children by their parent or legal guardian. Protocols were approved
by the Clinical Research Ethics Board (H07-02681).
RSV infection
The original human RSV strain A-2 was purchased from Advanced Biotechnol-
ogies (Columbia, MD, USA). For all mouse studies, the virus was propagated
in Vero cells (American Type Culture Collection, Manassas, VA, USA) using
serum-free medium (SFM4MegaVir; HyClone, Logan, UT, USA) and stored at
80°C. Five-day-old pups or adults were anesthetized with 5% isofluorane and
infected intranasally with 2  105 50% tissue culture-infective dose/g body
weight of RSV in 10 l (for pups) or 50 l (for adults) serum-free medium. In
some experiments, mice were sham-infected with serum-free medium. For
stimulation of human PBMCs and CBMCs, the virus was propagated in HEp-2
cells (Hybrid Diagnostics, Athens, OH, USA) using minimal essential medium
with Earle’s salts, containing 2% FBS and 1 mM sodium pyruvate (HyClone),
and purified further by ultracentrifugation on a discontinuous sucrose gradi-
ent [28].
Pulmonary function test
Airway resistance upon MeCh (Sigma-Aldrich, St. Louis, MO, USA) challenge
was measured using the flexiVent system (Scireq, Montreal, QC, Canada).
Mice were anesthetized with ketamine/xylazine (180/10 mg/kg body weight),
tracheotomized, and ventilated with a computer-controlled piston pump. The
pressure and volume of the airway were recorded and fitted into a single com-
partment model to calculate airway resistance. Raw data were normalized by
subtracting individual baseline values (resistance at 0 mg/ml MeCh) and plot-
ted as normalized resistance. Baseline values were not statistically different
among the groups.
Lung histopathology
Mice were killed and retrograde perfusion performed to remove blood from
the lungs, which were then gently inflated and fixed with zinc formalin
(Thermo Fisher Scientific, Waltham, MA, USA). After fixation, lungs were em-
bedded in paraffin, sectioned, and mounted on slides; then, the slides were
stained with H&E or PAS to identify cellular infiltrates or mucus production in
the airway epithelial cells, respectively. Lung sections were stained by H&E and
visualized under high magnification (60). Eosinophils were quantified in the
peribronchial tissues of lung specimens in a blinded manner and expressed as
number of eosinophils/surface area of the lung parenchyma. Mucus expres-
sion in the airway epithelial cells was detected by PAS staining and images ac-
quired. Images were analyzed with ImageJ [29]. Mucus expression was quanti-
fied and expressed as area of mucus-positive cells/surface area of airway epi-
thelial cells.
T cell activation assay
To measure the proliferative ability of lung Th cells in vitro, T cell activation
assay was performed [30]. Briefly, pulmonary CD11c cells were isolated from
naïve, adult mice with a mouse CD11c-positive selection kit from Stemcell
Technologies (Vancouver, BC, Canada) and infected with RSV (MOI50) for
18 h. Lung CD4 T cells were selected with a mouse CD4-positive selection kit
(Stemcell Technologies) and stained with 0.5 M CFSE (Life Technologies,
Carlsbad, CA, USA). CD4 cells (5104) were then cocultured with 5  103
CD11c cells in the presence of 1 g/ml CD3 antibody (clone #17A2; eBiosci-
ence, San Diego, CA, USA) for 72 h. The cells were stimulated, stained,
and subjected to flow cytometry to determine the Th populations and
CFSE signals in each population. The feasibility of this T cell activation
assay was tested using increasing infectious doses of RSV, with or with-
out CD3 antibody (Supplemental Fig. 1).
BALF cellularity
BALFs were isolated by flushing lungs with 1 ml PBS containing 2% heat-inac-
tivated FBS. Total cell numbers were counted with a hemocytometer. BALF
cells were centrifuged onto slides and stained with a Hema-3 staining kit
(Thermo Fisher Scientific). Differential cell counts were determined by two
unbiased observers using standard morphological criteria.
Cytokine assay
Cytokine levels in the BALF were measured using a Milliplex mouse cytokine/
chemokine assay kit (Millipore, Billerica, MA, USA) on the Bioplex system
(Bio-Rad Laboratories, Hercules, CA, USA), as per the manufacturer’s instruc-
tion. Each sample was assayed in duplicate for type I cytokines, IFN- and
IL-12 (p40), and type II cytokines, IL-4 and IL-13. Data presented herein ex-
cluded any number outside of the sensitivity level of each cytokine.
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Cell staining and flow cytometry
To determine the Th cell population in the lung, lung single-cell suspension
was isolated using the gentleMACS Octo Dissociator and lung dissociation kit
(Miltenyi Biotec, Auburn, CA, USA). The cells were then stimulated for 5 h at
37°C in stimulation media containing RPMI 1640 (HyClone), 10% heat inacti-
vated FBS (Life Technologies), 100 U/ml penicillin (HyClone), 100 mg/ml
streptomycin (HyClone), 5 ng/ml PMA (Sigma-Aldrich), and 500 ng/ml iono-
mycin (Sigma-Aldrich) in the presence of a protein transport inhibitor (1 l/
106 cells; GolgiPlug; BD Biosciences, Franklin Lakes, NJ, USA). After stimula-
tion, the cells were stained with fixable viability dye (eBioscience); fixed and
permeabilized with intracellular fixation and permeabilization buffer (eBiosci-
ence); and stained with antibodies to CD3 (clone #17A2; eBioscience), CD4
(clone #RM4-4; BioLegend, San Diego, CA, USA), IFN- (clone #XMG1.2;
eBioscience), and IL-4 (clone #BVD6-24G2; eBioscience). The flow data were
acquired with a Canto II flow cytometer (BD Biosciences), analyzed, and plot-
ted with FlowJo software (version 7.6.5 for Windows; Tree Star, Ashland, OR,
USA).
To determine the proliferation of Th cell populations in the T cell activa-
tion assay, the cells collected from the CD11c and CD4 cell coculture were
stimulated and stained as above and subjected to flow cytometry to measure
the CFSE signal in each Th population.
To measure IL-4R expression level on pulmonary Th cells, lung cells were
isolated as above. The single-cell suspension was then stained with fixable via-
bility dye and antibodies to CD3 (clone #17A2; eBioscience), CD4 (clone
#RM4-4; BioLegend), IL-4R (clone #mIL-4R-M1; BD Biosciences), and PE-
labeled streptavidin (eBioscience) and subjected to flow cytometry.
To correlate our mouse data to humans, we also measured the expression
level of IL-4R on Th cells from CBMCs and adult PBMCs, with or without
RSV stimulation in vitro. For this purpose, PBMCs from seven healthy adult
volunteers and CBMCs from seven term neonatal subjects were isolated by Fi-
coll extraction. PBMCs or CBMCs were infected with RSV or media at a MOI
of 2 in RPMI 1640 (HyClone), containing 10% heat-inactivated FBS (Hy-
Clone) and 1 mM sodium pyruvate. Cells were harvested after 48 h, resus-
pended in FACS lysing solution (BD Biosciences), and stored at 80°C until
staining. For staining, cells were thawed; permeabilized in FACS permeabiliza-
tion buffer (eBioscience); and stained by antibodies to CD3 (clone #SP34-2
from BD Biosciences or clone #OKT3 from eBioscience), CD4 (clone #RPA-
T4; eBioscience), T-bet (clone #4B10; eBioscience), and IL-4R (clone
#hIL4R-M57; BD Biosciences). The staining profile was acquired on an LSR II
flow cytometer (BD Biosciences). Given the heterogeneity in human immune
responses, we calculated the iMFI of IL-4R-positive cells by multiplying the
relative frequency (percent positive) of cells expressing IL-4R with the MFI of
that population. iMFI had been shown to correlate better with vaccine-induced
protection from Leishmania major challenge than either the percentage or the
MFI of the cytokine-positive population [31].
Statistics
All data were plotted as means  sem using Prism5 (GraphPad Software, La
Jolla, CA, USA). The statistics were analyzed with Prism5 or InStat 3 (Graph-
Pad Software). Two-way ANOVA and Bonferroni post hoc tests were used to
compare between the groups for the pulmonary function tests. Student’s t-test
was used for comparisons between ARR versus NRR mice for Th populations,
BALF cellularity, cytokines, and IL-4R expression. Mann-Whitney test was
used to compare the expression level of IL-4R between infant and adult Th
cells. One-way ANOVA and Bonferroni post hoc tests were used to test for dif-
ferences among IL4R/Lox, LckcreIL4R/Lox, IL4R/LoxRR, and
LckcreIL4R/LoxRR mice. Differences were considered significant if P  0.05.
Online Supplemental material
Supplemental Fig. 1 demonstrated the feasibility of using CD3 antibody in the
in vitro Th activation assay. Supplemental Fig. 2 showed that pulmonary viral
load and Th responses during primary infection were similar, between 5- and
12-week-old mice.
RESULTS
Neonatal RSV infection induced airway hyper-reactivity
and lung histopathology upon reinfection
To model the unique pathophysiological effects that RSV infec-
tion has on infants, we infected 5-day-old pups or adult mice
(6–8 weeks) with RSV and then reinfected these mice at 4 weeks
postprimary infection. At 6 days postreinfection, we assessed pul-
monary function and evaluated pulmonary pathology. Pulmonary
viral load data from other groups have shown that RSV infects
and replicates in the lung during secondary infection [11]. As
shown in Fig. 1A, NRR mice exhibited significantly greater airway
resistance following MeCh challenge than ARR mice (6.160.99
vs. 1.880.26 cm H2O·s/ml at 50 mg/ml MeCh), indicating that
neonatal primary infection but not adult primary infection results
in airways hyper-reactivity upon reinfection. Histological analysis
of lung sections from NRR and ARR mice revealed similar levels
of perivascular and peribronchiolar inflammation between NRR
and ARR mice (Fig. 1B). However, significantly more eosinophils
were observed in the lungs of NRR versus ARR mice (932151
vs. 4615 cells/mm2 surface area of epithelium). Additionally, we
observed a substantial amount of mucus cell hyperplasia and mu-
cus hyperproduction in mice infected as neonates, whereas ARR
mice exhibited little-to-moderate levels of mucus-positive staining
cells in the airways (Fig. 1C). In fact, the area of mucus-positive
cells in the airways of NRR mice was significantly greater than in
ARR mice (0.470.04 vs. 0.080.02 m2/m2 epithelium). Oc-
casionally, we observed sloughing epithelial cells in the airway of
NRR mice (data not shown), and this was not observed in any of
the lung sections from ARR mice.
Based on our previous studies in neonates and weanlings [9],
we thought it was highly unlikely that age at reinfection (i.e., 5 or
10–12 weeks) had a substantial effect on Th cell responses follow-
ing reinfection. However, to address this, we monitored pulmo-
nary viral loads at 1, 2, and 4 dpi and Th cell responses at 6 days
postprimary infection from mice infected at 5 or 12 weeks old. As
expected, there was no difference in pulmonary viral load or pri-
mary T cell response (Supplemental Fig. 2) between these two
groups. These data sustain that the differences we are observing
are associated with the age difference at primary but not second-
ary infection.
Neonatal RSV infection induced an exaggerated Th2
response upon reinfection
We further examined the immune responses to RSV reinfection
in the lungs of mice infected as neonates (NRR) or adults (ARR).
Six days postreinfection, lung cells were isolated from NRR and
ARR mice and Th subsets analyzed by flow cytometry (Fig. 2A
and B). RSV reinfection induced substantial amounts of Th1
(IFN--expressing CD4 T) cells in both NRR and ARR mice
(21.032.65 and 16.192.21%). However, NRR mice recruited
six-fold more Th2 (IL-4-expressing CD4 T) cells to the lung
compared with ARR mice (3.80.98 vs. 0.460.12%). More in-
terestingly, NRR mice had a subset of “multifunctional” Th cells
that coexpressed the prototypical Th1 cytokine IFN- and Th2
cytokine IL-4. These data demonstrate that mice infected as neo-
nates elicited a Th2-biased immune response in the lung upon
secondary RSV infection.
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There was no significant difference in the total number
of leukocytes recovered from the BALF between NRR and
ARR mice (Fig. 2C). Significantly more macrophages were
observed in the BALF of NRR compared with ARR mice
(79,98712,516 vs. 38,4565367). In concordance with the
exaggerated Th2 response, NRR mice also possessed a sub-
stantially greater number of eosinophils in the BALF com-
pared with ARR mice (33,21714,988 vs. 0; Fig. 2C). Finally,
Th2 cytokines, such as IL-4 and IL-13, were readily detectable
in the BALF of NRR mice and were secreted at significantly
elevated levels compared with ARR mice (9.402.09 pg/ml vs.
nondetectable and 68.4210.56 vs. 23.461.85 pg/ml, respec-
tively; Fig. 2D). Consistent with increased Th2 cytokine secre-
tion, NRR mice secreted significantly less IL-12(p40)
(15.811.6 vs. 47.726.7 pg/ml) compared with ARR mice.
No significant difference was observed in IFN- levels between
NRR and ARR mice.
It is possible that the exaggerated Th2 response observed in
mice infected initially as neonates was a result of memory re-
sponses resulting from a skewed Th2 primary response. To test
this, we measured the primary CD4 T cell response in the
lungs of neonatal or adult mice at 6 dpi. As shown in Fig. 2E,
there were no difference in IL-4 or IL-4IFN- expressing
CD4 T cells between NR and AR. Interestingly, RSV infection
of neonates resulted in significantly lower levels of pulmonary
Th1 (IFN--expressing CD4) cells compared with adults
(2.990.35 vs.0.600.08%), suggesting that the exaggerated
Th2 response upon reinfection in neonatally infected mice was
not a result of a biased Th2 primary response.
IL-4R was up-regulated on Th cells upon reinfection
of mice infected initially as neonates
As IL-4 signaling is a determinant for Th cell development, we
measured the expression of the common component of the
IL-4R and IL-13R—IL-4R—on pulmonary Th cells of RSV-
infected mice. Five-day-old pups or adults were infected with
RSV and reinfected 4 weeks postprimary infection. At 2 days
postreinfection, lung cells were isolated and the expression of
IL-4R analyzed by flow cytometry. IL-4R expression was
higher on Th cells from NRR versus ARR mice (MFI:
735.6029.58 vs. 618.208.18; Fig. 3A and B). Furthermore,
Th1 and Th2 cells from NRR mice expressed more IL-4R
than those cells from the lungs of ARR mice (MFI:
891.0015.55 vs. 810.6015.33 and 1208.6044.07 vs.
767.8020.33, respectively; Fig. 3C). Interestingly, the ex-
pression of IL-4R on Th2 cells from NRR mice was signifi-
cantly higher than its expression on Th1 cells from the
same mice.
It is possible that IL-4R expression actually increased on
neonatal Th cells during primary infection. To test this, we
measured IL-4R expression on neonatal and adult CD4 T
cells at 2 days after primary infection. Surprisingly, IL-4R ex-
pression was decreased on naïve neonatal versus adult CD4 T
cells. However, with RSV infection, we observed a decrease in
IL-4R expression on adult but not neonatal CD4 T cells,
and as a result, IL-4R expression was similar on CD4 T cells
between RSV-infected neonates and adults. More importantly
and relevantly, neonatal Th1 and Th2 cells expressed higher
Figure 1. Neonatal RSV infection induced pulmonary immunopathophysiology upon reinfection. Neonates (5 days old; NRR) or adults (6–8 weeks
old; ARR) were infected and reinfected with RSV at 4 weeks postprimary infection. Airway resistance and lung histopathology were determined at 6 days
postsecondary infection. (A) Airway resistance was measured at baseline (0 mg/ml MeCh) and increasing doses of intratracheally delivered MeCh quan-
tify airway hyper-reactivity. At baseline, airway resistance was not different between the groups; therefore, individual responses were normalized to their
prospective baselines (i.e., subtracting resistance at 0 mg/ml MeCh from resistance value at dose) and plotted as normalized resistance; n  5; *P 
0.05. (B) H&E staining showing peribronchial inflammation. The arrows point to cellular infiltrates. Original scale bar  50 m. (C) PAS staining show-
ing airway mucus. Arrows point to mucus staining. The right panels are an enlargement of the rectangles in the left panels. Original scale bar  200 m.
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levels of IL-4R compared with their adult counterparts at pri-
mary infection. Without RSV infection, neonatal Th2 cells
showed significantly greater expression of IL-4R compared
with adult Th2 cells.
IL-4R expression was up-regulated on Th cells purified
from cord blood and stimulated with RSV in vitro
To begin to explore the translational potential of our findings,
we compared the expression level of IL-4R on CD4 T cells
purified from cord blood or adult peripheral blood. As shown
in Fig. 3D, Th cells from CBMCs or PBMCs expressed similar
levels of IL-4R without stimulation, as indicated by the com-
parable iMFI values (34621132 vs. 47661186). However,
when stimulated with RSV in vitro, IL-4R levels on Th cells
from CBMCs increased substantially and significantly com-
pared with IL-4R levels on Th cells from PBMCs (iMFI:
13,9313095 vs. 34621132). These data demonstrate that
IL-4R expression on infant CD4 T cells was up-regulated,
responding to RSV infection in humans.
Elevated IL-4R on CD4 T cells upon reinfection was
associated with hyperproliferation in vitro
To determine the mechanism by which Th2 bias occurs to RSV rein-
fection in neonatally infected mice, we examined the proliferative
ability of the Th cells from mice infected as neonates (NRR) or
adults (ARR) in vitro . Five-day-old pups or adults were infected with
RSV and reinfected at 4 weeks postprimary infection. At 6 days after
reinfection, lung CD4 cells were isolated and cocultured with RSV-
infected lung CD11c cells as APCs. Three days after coculture,
CD4 T cell subsets and their proliferation were measured. As
shown in Fig. 4A and B, CD4 T cells from NRR mice, when stimu-
lated in vitro with RSV, possessed the ability to differentiate into Th1
(20.680.31%) and Th2 (7.570.48%) cells. In contrast, CD4 T
cells from ARR mice developed predominantly into Th1 cells
(50.190.85%), with only 0.09% developing into Th2 cells. With the
use of CFSE dilution, we analyzed the proliferative capacity of Th
cells from NRR and ARR mice. We observed that 86.9  0.44% of
the Th2 cells from NRR mice had undergone cell division, whereas
only 39.04  7.59% of the Th2 cells from ARR mice divided into
further generations (Fig. 4C and D). Th1 cells also proliferated with
65.9  0.76% from NRR mice and 17.17  1.33% from ARR mice
undergoing cell division. In agreement with the IL-4R expression
data, these data indicated that CD4 T cells from NRR mice were
more proliferative, that there was increased proliferation of Th2 cells
from NRR mice, and that Th2 cells predominated in NRR mice.
Th cell-specific deletion of Il4ra abolished airway
hyper-reactivity and lung histopathology upon
reinfection in mice infected initially as neonates
As greater levels of IL-4R expression on pulmonary CD4 T
cells were associated with neonatal RSV infection-induced patho-
physiological consequences, we hypothesized that IL-4R signal-
ing was responsible for the observed phenotype. To investigate
the role of IL-4R on CD4 T cells, we infected mice specifically
lacking IL-4R on CD4 T cells (LckcreIL4R/Lox) and their
littermate controls (IL-4R/lox) at 5 days of age and subse-
quently reinfected those mice with RSV, 4 weeks later
(LckcreIL4R/Lox-RR and IL4R/Lox-RR, respectively). Control
mice, including IL-4R-deficient and -competent mice, were
mock-infected with viral production media (LckcreIL4R/Lox-Sham
and IL4R/Lox-Sham, respectively). Pulmonary function and lung
histopathology were determined at 6 days after reinfection.
Figure 2. Neonatal RSV infection induced an ex-
aggerated Th2 response upon reinfection. Neo-
nates (5 days old; NRR) or adults (6–8 weeks old;
ARR) were infected and reinfected with RSV at 4
weeks postprimary infection. Pulmonary Th cell sub-
sets and BALF cellularity and cytokine levels were
measured at 6 days postsecondary infection. (A) Pul-
monary Th profile during secondary infection. Lung
cells were isolated from NRR and ARR mice, stimu-
lated in vitro with PMA and ionomycin, and stained
with dead cell, excluding dye and antibodies to
CD3, CD4, IFN-, and IL-4. The cells were then ana-
lyzed by flow cytometry. Lines indicate the mean of
each group; n  10. (B) Representative dot plots
showing the IL-4- and IFN--expressing Th cells in ARR and NRR mice. (C) BALF cellularity; n  5. (D) Cytokine levels in the BALF. Th1 cytokines:
IFN- and IL-12; Th2 cytokines: IL-4 and IL-13; n  4–8. N.D., Not detected. (E) Pulmonary Th profile during primary infection. Lung cells were iso-
lated from NR or AR mice and stimulated, stained, and analyzed as in B. Lines indicate the mean of each group; n  4; *P  0.05.
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As shown in Fig. 5A, no statistical difference in airways
resistance was observed between the two sham-infected
mouse genotypes (i.e., LckcreIL4R/Lox-Sham and IL4R/Lox-
Sham), indicating that specific deletion of Il4ra in CD4 T
cells did not induce a baseline change in pulmonary function. As
expected, RSV reinfection of the IL-4R-competent mice
(IL4R/Lox-RR) induced airway hyper-reactivity, as evidenced by
the increase in airways resistance compared with the sham-in-
fected control mice (IL4R/Lox-Sham) in response to MeCh
challenge. While in the absence of CD T cell-specific IL-4R,
RSV reinfection failed to induce airway hyper-reactivity
(LckcreIL4R/Lox-RR vs. IL4R/Lox-RR; 2.170.44 vs.
3.010.34 cm H2O·s/ml). Furthermore, there was no difference
between CD4 T cell-specific, IL-4R-deficient mice that were
RSV- or SHAM-reinfected (LckcreIL4R/Lox-RR vs.
LckcreIL4R/Lox-Sham; 2.170.44 vs. 2.430.18 cm H2O·s/ml),
indicating a complete abrogation of airway hyper-reactivity in the
CD4 T cell-specific, IL-4R-deficient mice.
Supporting the pulmonary function data, we observed a sub-
stantial decrease in perivascular and peribronchiolar inflamma-
tion in CD4 T cell-specific, IL-4R-deficient mice
(LckcreIL4R/Lox-RR) compared with the IL-4R-competent
mice (IL4R/Lox-RR; Fig. 5B). In particular, substantially less
eosinophils were observed in LckcreIL4R/Lox-RR mice com-
pared with IL4R/Lox-RR mice (106 vs. 559128 cells/mm2
surface area). Additionally, little-to-no mucus was observed in the
airways of the CD4 T cell-specific, IL-4R-deficient mice,
whereas we observed a significant amount of mucus produc-
tion and mucus cell hyperplasia in the IL-4R-competent
mice (Fig. 5C; 0.0060.005 vs. 0.250.04 m2 area of
mucuscells/m2 area of epithelium). No pulmonary in-
flammation or airway mucus was observed in IL-4R-deficient or
-competent, sham-infected mice (data now shown). These data
demonstrated a requirement for CD4 T cell-specific IL-4R in
pulmonary dysfunction and histopathology associated with RSV
reinfection in neonatally infected mice.
Th-specific deletion of Il4ra attenuated Th2 responses
to reinfection in mice infected initially as neonates
To understand how the absence of IL-4R on CD4 T cells af-
fected the pulmonary immune response to RSV reinfection, we
analyzed the pulmonary immune response in the above mice.
Figure 3. IL-4R was up-regulated
upon reinfection on Th cells from
mice infected originally as
neonates. Neonates (5 days old;
NRR) or adults (6–8 weeks old;
ARR) were infected and reinfected
with RSV at 4 weeks postprimary
infection. The expression of IL-
4R on Th cells and Th subsets
was determined by flow cytometry
at 2 days postsecondary infection.
Lung cells were isolated from NRR
and ARR mice, stimulated in vitro,
and stained with dead cell, exclud-
ing dye and antibodies to CD3,
CD4, IFN-, IL-4, and IL-4R. (A)
Relative expression level of IL-4R
on CD4 Th cells indicated by
MFI of IL-4R; n  5. (B) Repre-
sentative histogram showing the
staining profile of IL-4R on Th
cells. IL-4R fluorescence minus
one (FMO) serves as a negative
control for IL-4R staining. (C)
Relative expression level of IL-4R
on CD4 Th1 or Th2 cells, indi-
cated by MFI of IL-4R; n  5.
(D) Relative expression level of
IL-4R on circulating Th cells
from cord blood of healthy term
infants or from peripheral blood
of healthy adults at baseline or
upon in vitro stimulation with
RSV. iMFI was calculated by multi-
plying the relative frequency (percent positive) of cells expressing IL-4R with MFI of that population; n  7. (E) IL-4R expression on neonatal
or adult CD4 T cells during primary RSV infection in mice. Neonates (5 days) or adults (6–8 weeks) were infected with RSV (NR and AR, re-
spectively) or media (NS and AS, respectively). IL-4R expression on CD4 T cells was measured at 2 dpi; n  5. NS, pups infected with media;
AS, adults infected with media. (F) IL-4R expression on neonatal or adult Th1 cells during primary RSV infection. Mice were treated and IL-4R
measured as in E; n  5. (G) IL-4R expression on neonatal or adult Th1 cells during primary RSV infection. Mice were treated and IL-4R mea-
sured as in E; n  5; *P  0.05.
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Pulmonary immunophenotyping, including CD4 T cell profile
and BALF cellularity and cytokine levels, were measured 6 days
after reinfection. As shown in Fig. 6A and B, sham-infected, IL-
4R-deficient and -competent mice failed to induce effector
CD4 T cells (i.e., few CD4 T cells expressed effector cytokines:
IFN- or IL-4. Reinfection with RSV induced substantial and simi-
lar amounts of the IFN--expressing Th1 cells in IL-4R-deficient
and -competent mice (21.801.41 vs. 20.483.52%) but failed to
induce significant amounts of IL-4-expressing Th2 cells or multi-
functional Th cells coexpressing IFN- and IL-4 (1.940.46 vs.
4.480.81% and 1.860.33 vs. 5.31.07%, respectively).
Consistent with the reduction in pulmonary Th2 cells, we ob-
served a significant reduction in eosinophils in the BALF of RSV-
reinfected, IL-4R-deficient versus -competent mice (1527541
vs. 19,20012,089; Fig. 6C). No differences in total BALF cell
numbers, alveolar macrophages, lymphocytes, or neutrophils
were observed between the two groups of mice. In addition, we
observed a significant decrease in Th2 cytokine IL-13 and an in-
crease in Th1 cytokine IL-12(p40) in the BALF of IL-4R-defi-
cient compared with -competent mice (59.4311.35 vs.
32.345.36 pg/ml and 21.582.47 vs. 12.182.28 pg/ml, respec-
tively; Fig. 6D). There was no difference in IFN- between IL-
4R-deficient and -competent mice upon RSV reinfection. These
data demonstrated that CD4 T cell-specific ablation of Il4ra at-
tenuated the pathogenic, Th2-biased immune responses associ-
ated with RSV reinfection in the neonatally infected mice.
DISCUSSION
It has been proposed that a biased Th2 immune response is re-
sponsible for RSV-induced pulmonary pathophysiology in infants.
In this study, we first confirmed that an exaggerated Th2 re-
sponse was induced by RSV reinfection in mice originally in-
fected as neonates but not as adults, and this Th2 immune re-
sponse correlated with airway hyper-reactivity, mucus hyperpro-
duction, and eosinophilia. We further observed increased
expression of IL-4R on CD4 T cells from mice infected initially
with RSV as neonates and reinfected with RSV as adults. In-
creased expression of IL-4R on Th cells was associated with an
increased ability of these cells to proliferate and develop into Th2
cells. Specific deletion of Il4ra on Th cells abolished airway hyper-
reactivity and mucus hyperproduction and attenuated airway eo-
sinophilia and pulmonary Th2 responses. We demonstrated fur-
ther that IL-4R expression was increased on human CD4 Th
cells from cord blood but not peripheral blood from adults upon
RSV stimulation in vitro, suggesting that the mechanisms that we
have identified in mice are translatable to humans.
Whereas human epidemiological studies suggest a gain-of-func-
tion association of IL4RA polymorphisms with severe RSV disease
in infants [22], few studies have investigated the function of IL-
4R in a neonatal model. We clearly showed that the expression
of IL-4R on CD4 T cells, including Th1 and Th2 cells, was in-
creased upon reinfection when the mice were infected initially as
neonates. This observation is in line with the study of Li et al.
[32], which showed increased expression of IL-13R1, the other
component of the type II IL-4R complex, on neonatal Th1 cells
upon antigen recall. Whereas Li and coworkers ’ data demon-
strated increased expression of IL-13R1, correlated with en-
hanced Th1 apoptosis, and suggested this as a mechanism
skewing the neonatal immune response toward a Th2-domi-
nant response, we were unable to observe any changes in Th1
apoptosis between RSV-infected and noninfected mice after sec-
ondary RSV infection (data not shown). What we did observe is
that Th1 and Th2 cells from mice infected initially as neonates
Figure 4. CD4 T cells from mice,
infected initially as neonates ver-
sus adults, were more proliferative
and were more prone to develop
into Th2 cells. Neonates (5 days
old; NRR) or adults (6–8 weeks
old; ARR) were infected and rein-
fected with RSV at 4 weeks postpri-
mary infection. At 6 days postsec-
ondary infection, pulmonary
CD4 T cells from NRR and ARR
mice were isolated, stained with
CFSE, and cocultured with RSV-
infected lung CD11c cells
(APCs) for 3 days. Cells were then
collected and stained with dead
cell, excluding dye and antibodies
to CD3, CD4, IFN-, and IL-4. The
cells were analyzed by flow cytom-
etry to access the Th subsets and
proliferation. Cytokines secreted
into the medium were measured
with multiplex cytokine assays. (A)
Th cell profile. Lines indicate the
mean of each group; n  5. (B)
Representative dot plots showing Th cells expressing IFN- or IL-4. (C) Proliferation of Th1 and Th2 cells, as indicated by CFSE dilution; n  5.
(D) Representative histogram showing the division of Th1 and Th2 cells; *P  0.05.
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possess better proliferative ability than cells from mice infected as
adults. Moreover, Th2 cells from mice infected initially as neo-
nates showed the greatest ability to proliferate. This is consistent
with the observation that RSV reinfection resulted in increased
numbers of pulmonary Th2 cells without an increase in the num-
bers of Th1 cells in mice infected initially as neonates compared
with mice infected initially as adults. Cumulatively, these data sug-
gest exaggerated Th2 cell proliferation rather than Th1 apoptosis
as a mechanism inducing biased Th2 responses during reinfec-
tion in neonatally infected mice.
It was unexpected that in mice, primary RSV infection did
not increase the expression of IL-4R on neonatal CD4 T
cells but rather decreased IL-4R expression on adult CD4 T
cells. This is in contrast to the ex vivo human CD4 T cell
data, which demonstrated an increase in IL-4R expression on
CD4 T cells from CBMCs versus adult PBMCs exposed to
RSV. Although not significant but similar to the mouse in vivo
data, IL-4R expression appeared to decrease on PBMC CD4
T cells. This discrepancy between mouse and human data
could be a result of a variety of factors. First, humans are rein-
fected by RSV throughout life [4], and therefore, a portion of
the PBMC CD4 T cells is likely effector or memory cells
masking the inhibitory effect of RSV infection on IL-4R ex-
pression on adult CD4 T cells. Second, mouse data were de-
rived from in vivo experiments, whereas human data were de-
rived from in vitro stimulations and studies. Finally, it is diffi-
cult to achieve a MOI of two in vivo as a result of the fact that
there are much more cells in actual airways than cultured
cells. Therefore, no change in IL-4R expression on neonatal
CD4 T cells may reflect the fact that not enough cells were
infected. Nevertheless, Th1 and Th2 cells from RSV-infected
neonates showed higher expression of IL-4R than cells from
RSV-infected adult mice, and this is consistent with the human
data, in that CBMC CD4 T cells expressed more IL-4R than
PBMC CD4 T cells when stimulated with RSV. Intriguingly,
Th2 cells also expressed higher levels of IL-4R than Th1 cells
from RSV-infected neonates. Although beyond the scope of
these studies, this suggests that the elevated expression of IL-
4R may increase the survival of memory Th2 cells preferen-
tially and that those cells may undergo favored proliferation
during reinfection.
The absence of IL-4R on CD4 T cells abolished the im-
munopathophysiology associated with RSV reinfection in mice
originally infected as neonates, including airway hyper-reactiv-
ity, eosinophilia, and mucus hyperproduction. Surprisingly,
unlike the drastic effects on pathophysiology, the deletion of
Il4ra from CD4 T cells did not inhibit completely the devel-
opment of Th2 or multifunctional Th cells coexpressing IFN-
and IL-4. One possible explanation is the often-reported, par-
tial efficiency of Cre recombinase [33]; however, the original
report on this mouse line demonstrated 95% efficiency for
disruption of CD4 T cell-specific IL-4R [26]. It seems un-
likely that the residual 5% expression of full-length IL-4R
could explain the percentage of Th2 and multifunctional Th
cells that were induced upon reinfection of these mice. In-
stead, we believe that the Th2 and multifunctional Th cells
Figure 5. CD4 T cell-specific deletion of IL4ra abolished neonatal RSV infection-induced immunopathophysiology upon reinfection. Th-specific,
IL-4R-deficient (LckcreIL4R/Lox-RR) and -competent mice (IL4R/Lox-RR) were infected with RSV at 5 days old and reinfected at 4 weeks postpri-
mary infection. Control mice of each genotype were treated with serum-free medium (LckcreIL4R/Lox-sham and IL4R/Lox-sham, respectively). Pul-
monary function and lung histopathology were determined at 6 days postreinfection. (A) Airway resistance was measured at baseline (0 mg/ml MeCh)
and increasing doses of intratracheally delivered MeCh to quantify airway hyper-reactivity. At baseline, airway resistance was not different between the
groups; therefore, individual responses were normalized to their prospective baselines and normalized resistance plotted; n  5–7; *P  0.05. (B) H&E
staining, demonstrating pulmonary inflammation. The arrow points to cellular infiltrates. Original scale bar  50 m. (C) PAS staining showing airway
mucus. The arrow points to mucus staining. The right panels are enlargements of the rectangles in the left panels. Original scale bar  200 m.
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observed following RSV reinfection indicate an IL-4R-inde-
pendent Th2 commitment/maintenance mechanism, as has
been suggested previously in the context of different patho-
gens or allergens [34–38]. In addition, the abrogation of the
Th2-associated pathophysiology, despite the presence of resid-
ual Th2 cells in the lungs, suggests that either Th2 effector
functions require a minimal number of Th2 cells (or a mini-
mal release of Th2 effector cytokines) to induce functional
responses or current measurements of Th2-induced pathophys-
iology are not sensitive enough to detect these responses. It is
also possible that undefined mediators released by IL-4R-ex-
pressing CD4 T cells are responsible for RSV-induced patho-
physiology and that upon ablation of these cells, those media-
tors are lost, resulting in a reduction in pathophysiology.
As mentioned above, reinfection of neonatally infected
mice induced not only Th2 cells expressing IL-4 but also a
multifunctional Th subset expressing the prototypical Th2
and Th1 cytokines, IL-4, and IFN-. Intriguingly, this multi-
functional subset was only observed in neonatally infected
mice, where IL-4R was up-regulated upon reinfection and
not in mice infected as adults. Furthermore, the number of
multifunctional Th cells was reduced drastically in Th-spe-
cific, IL-4R-deficient mice. These observations indicated
that IL-4R is partially required for the development of
these cells. The exact role of these multifunctional cells is
uncertain, and a few studies suggest that they are simply an
immature cell type (i.e., Th0 cells) in the process of com-
mitting to a Th1 or Th2 cell [25, 39, 40]. From our data, it
is unclear if and how these cells might function in the
pathogenesis of neonatal RSV infection.
In summary, we confirmed that skewed Th2 immune re-
sponses with airway hyper-reactivity, mucus hyperproduction,
and eosinophilia are induced upon RSV reinfection, specifi-
cally in neonatally infected mice. This skewed Th2 response
correlated with increased IL-4R expression on CD4 T cells.
Furthermore, deletion of Il4ra from Th cells attenuated Th2
responses and abolished Th2-associated immunopathophysiol-
ogy. The increase in IL-4R expression was also observed in
CD4 T cells from CBMCs, suggesting that IL-4R may also
have a role in RSV pathogenesis in human infants. These find-
ings elucidate a pathogenic role for Th-specific IL-4R during
RSV reinfection in mice infected as neonates and provide im-
portant insight for infant RSV vaccine development.
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